Abstract:Advancing age leads to an accumulation of senescent endothelial cells (ECs) within arteries. Senescent cells have undergone permanent cell cycle arrest, are pro‐oxidative and pro‐inflammatory, and therefore represent a likely cause of age‐related EC dysfunction. Yet, the molecular mechanisms and physiological consequences of EC senescence remain incompletely understood. Telomeres are repeat DNA sequences that cap chromosomes. Telomeres shorten with each cell division and are highly susceptible to oxidative damage. When telomeres become critically short or damaged, they become uncapped, which activates the DNA damage response and leads to cellular senescence. Here, we tested the hypothesis that aging results in EC telomere uncapping that induces senescence, leading to physiological hallmarks of aging. To assess whether aging results in EC telomere uncapping, we compared ECs from young (~3 mo) and old (~27 mo) mice. Aging resulted in ~4‐fold greater EC telomere uncapping (p<0.001, Figure 1A). To determine if EC telomere uncapping induces senescence, we deleted the telomere capping protein, TRF2, in ECs of young (~3.5mo) mice (TRF2‐ecKO). Compared to wildtype (WT) littermate controls, TRF2‐ecKO mice had a ~78% reduction in TRF2 gene expression (p<0.0001). TRF2 deletion reduced EC division by ~47% (p<0.0001, Figure 1B), indicative of senescence. To examine the physiological consequences of EC senescence, we examined hallmarks of vascular aging including perfused microvascular density and endothelium‐dependent dilation (EDD). TRF2‐ecKO mice had an ~18% reduction in perfused mesenteric microvessels between 5‐25 µM (p<0.001, Figure 1C). Likewise, TRF2‐ecKO displayed ~26% reduction in mesenteric artery EDD compared to WT mice (p<0.05, Figure 1D). Furthermore, TRF2‐ecKO arterial EDD was ameliorated by the superoxide scavenger, TEMPOL (p>0.05, Figure 1D). Endothelium‐independent dilation to the exogenous nitric oxide donor sodium nitroprusside was not different between WT and TRF2‑ecKO mice (p>0.05). These data suggest EC telomere uncapping leads to senescence that reduces perfused microvascular density, and to elevated oxidative stress that suppresses EDD, similar to advanced age. To assess metabolic and muscle function, we performed an intraperitoneal glucose tolerance test (GTT, 2g/kg body mass) and a forelimb grip strength test. TRF2‐ecKO mice had ~21% greater area under the curve during GTT compared to WT mice (p<0.05, Figure 2A) as well as a ~14% reduction in grip strength (p<0.05, Figure2B). Taken together, these data provide evidence that aging results in EC telomere uncapping that induces senescence and age‐related physiological dysfunction.

Cellular senescence promotes endothelial activation through epigenetic alteration, and consequently accelerates atherosclerosis

Pro‐inflammatory cytokines mediating senescence of vascular endothelial cells in atherosclerosis

Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging

Senescent endothelial cells promote pathogenic neutrophil trafficking in inflamed tissues

Understanding the Intricacies of Cellular Senescence in Atherosclerosis: Mechanisms and Therapeutic Implications

Aging results in endothelial cell telomere uncapping that induces senescence and physiological dysfunction

P4500Cellular senescence of endothelial cells impairs angiogenesis by altering energy metabolism through p53-tigar axis

Abstract 100: Omics Strategies To Identify Senescent Cells Mediating Extracellular Matrix Remodeling During Vascular Disease

Cyclin-Dependent Kinase 5-Mediated Hyperphosphorylation Of Sirtuin-1 Contributes To The Development Of Endothelial Senescene And Atherosclerosis

The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis

Cellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy

Endothelial cell telomere dysfunction induces senescence and results in vascular and metabolic impairments

Endothelial Senescence and the Chronic Vascular Diseases: Challenges and Therapeutic Opportunities in Atherosclerosis

Targeting vascular senescence in cardiovascular disease with aging

Cyclin-dependent kinase 5-mediated hyperphosphorylation of sirtuin-1 contributes to the development of endothelial senescence and atherosclerosis

Cellular Senescence in Arterial Diseases

Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors

New Dawn for Atherosclerosis: Vascular Endothelial Cell Senescence and Death

Endothelial Cell Senescence and Age-Related Vascular Diseases

Advances in Relationship Between Cell Senescence and Atherosclerosis.

Targeting Molecular Mechanism of Vascular Smooth Muscle Senescence Induced by Angiotensin II, A Potential Therapy via Senolytics and Senomorphics